|Partial Close, 5/2009 ||$630k|
|Series A, 9/2012 |
Silicon Valley Bank
|Series B, 8/2013 ||$7M|
Freedom Meditech is a private, growth-stage medical device company focused on the development and commercialization of first-to-market, non-invasive, ophthalmic medical devices for both chronic disease detection (ClearPath DS-120) and the management of diabetes (I-SugarX). The hallmark of their product portfolio is to provide “free and healthy” alternatives to existing diagnostic tools on the market for the detection, monitoring and management of chronic diseases.